Mirtazapine Tablet, Film Coated
Product Images NDC 65862-031

5 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 65862-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablet Bottle))

Package Label-principal Display Panel (7.5 mg (100 Tablet Bottle))
Label for Mirtazapine Tablets USP, 7.5 mg strength, film-coated tablet form, distributed by Aurobindo Pharma USA, Inc. The label highlights prescription use, pharmacist dispensing instructions, dosage storage conditions, packaging quantity of 100 tablets, and includes the NDC 65862-001-01. It also specifies the product is made in India by Aurobindo.*
FDA Label Image

Package Label-principal Display Panel (15 mg (100 Tablet Bottle))

Package Label-principal Display Panel (15 mg (100 Tablet Bottle))
Label for Mirtazapine Tablets USP 15 mg by Aurobindo Pharma Limited. The label indicates a bottle of 100 film-coated tablets. It includes storage instructions, dosage guidance to read enclosed prescribing information, and distribution details for Aurobindo Pharma USA, Inc. with an address in East Windsor, NJ. The label also has a barcode and a printed note emphasizing pharmacist dispensing with the medication guide separately.*
FDA Label Image

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))
Mirtazapine Tablets, USP 30 mg film-coated tablets, label from Aurobindo Pharma Limited. The label states the product contains 100 tablets, provides storage instructions at 25°C with permitted excursions, and directs pharmacists to dispense with a separate medication guide. The product is distributed by Aurobindo Pharma USA, Inc., made in India. The NDC code visible is 65862-003-01.*
FDA Label Image

Package Label-principal Display Panel (45 mg (100 Tablet Bottle))

Package Label-principal Display Panel (45 mg (100 Tablet Bottle))
Label for Mirtazapine Tablets, USP 45 mg film-coated tablets by Aurobindo Pharma Limited. The label states the package contains 100 tablets and includes storage instructions (store at 25°C with permitted excursions). It also indicates distribution by Aurobindo Pharma USA, Inc. and that the product is made in India. Additional details include the NDC code and instructions to dispense with a medication guide.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure diagram of Mirtazapine. The image shows the molecular framework including nitrogen-containing rings and a methyl group attached to one of the nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.